DK0588477T3 - Medicinsk præparat omfatende TCF-11 - Google Patents

Medicinsk præparat omfatende TCF-11

Info

Publication number
DK0588477T3
DK0588477T3 DK93305602.0T DK93305602T DK0588477T3 DK 0588477 T3 DK0588477 T3 DK 0588477T3 DK 93305602 T DK93305602 T DK 93305602T DK 0588477 T3 DK0588477 T3 DK 0588477T3
Authority
DK
Denmark
Prior art keywords
tcf
medical preparation
derived
wound healing
particularly effective
Prior art date
Application number
DK93305602.0T
Other languages
Danish (da)
English (en)
Inventor
Kanji Higashio
Hiroaki Masunaga
Nobuaki Fujise
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21222992A external-priority patent/JP3380573B2/ja
Priority claimed from JP21222792A external-priority patent/JP3619526B2/ja
Priority claimed from JP4234198A external-priority patent/JPH0656692A/ja
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DK0588477T3 publication Critical patent/DK0588477T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93305602.0T 1992-07-16 1993-07-16 Medicinsk præparat omfatende TCF-11 DK0588477T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21222992A JP3380573B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP21222792A JP3619526B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
JP4234198A JPH0656692A (ja) 1992-08-10 1992-08-10 Ｔｃｆ−ｉｉを有効成分とする創傷治療剤

Publications (1)

Publication Number Publication Date
DK0588477T3 true DK0588477T3 (da) 1998-03-30

Family

ID=27329338

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97100939T DK0821969T3 (da) 1992-07-16 1993-07-16 Medicinsk sammensætning omfattende TCF-II
DK93305602.0T DK0588477T3 (da) 1992-07-16 1993-07-16 Medicinsk præparat omfatende TCF-11

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK97100939T DK0821969T3 (da) 1992-07-16 1993-07-16 Medicinsk sammensætning omfattende TCF-II

Country Status (7)

Country Link
EP (3) EP0588477B1 (ko)
KR (1) KR100271087B1 (ko)
AT (3) ATE345809T1 (ko)
CA (1) CA2100720C (ko)
DE (3) DE69334087T2 (ko)
DK (2) DK0821969T3 (ko)
ES (2) ES2276409T3 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330960T2 (de) * 1992-07-16 2002-04-11 Snow Brand Milk Products Co Ltd Normalisierer der blutkoagulation enthaltend tcf-ii als aktiven bestandteil
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
JP3680114B2 (ja) * 1993-09-17 2005-08-10 敏一 中村 脳神経障害治療剤
NZ298141A (en) * 1994-12-27 2000-12-22 Snow Brand Milk Products Co Ltd Treating lipid metabolism disorder using TCF-II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
US20020041863A1 (en) 1997-03-14 2002-04-11 Masamichi Kojiro Preventive and/or therapeutic agent for cachexia
JP3961064B2 (ja) 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904753A (en) * 1970-02-20 1975-09-09 Research Corp Clinically active bovine growth hormone fraction
JPS58146293A (ja) 1982-02-26 1983-08-31 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製造方法
US4708948A (en) 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
DE3419184A1 (de) 1984-05-23 1985-11-28 Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart Zuendverteileranordnung an brennkraftmaschinen
JPS62103021A (ja) 1985-10-28 1987-05-13 Yoshitomi Pharmaceut Ind Ltd 細胞障害作用を有する生理活性物質およびその製造方法
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
JPS6410998A (en) 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
NZ232813A (en) 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
DE69130494T2 (de) * 1990-06-11 1999-07-08 Toshikazu Nakamura Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
JP2634323B2 (ja) 1990-07-13 1997-07-23 雪印乳業株式会社 Ｔｃｆ‐▲ｉｉ▼のアミノ酸配列をコードするｄｎａを含むプラスミド，形質転換細胞及びこれを用いて生理活性物質を生産する方法

Also Published As

Publication number Publication date
DE69334281D1 (de) 2009-05-28
EP1719522B1 (en) 2009-04-15
DE69334087T2 (de) 2007-07-05
ATE159171T1 (de) 1997-11-15
EP0821969A3 (en) 2000-12-13
DE69314586T2 (de) 1998-02-19
AU673835B2 (en) 1996-11-28
ES2276409T3 (es) 2007-06-16
CA2100720C (en) 2003-03-11
ATE428438T1 (de) 2009-05-15
EP1719522A1 (en) 2006-11-08
DE69314586D1 (de) 1997-11-20
KR940005286A (ko) 1994-03-21
CA2100720A1 (en) 1994-01-17
KR100271087B1 (en) 2000-11-01
EP0588477A2 (en) 1994-03-23
AU4194593A (en) 1994-01-20
ATE345809T1 (de) 2006-12-15
ES2110057T3 (es) 1998-02-01
DE69334087D1 (de) 2007-01-04
DK0821969T3 (da) 2007-03-26
EP0821969B1 (en) 2006-11-22
EP0821969A2 (en) 1998-02-04
EP0588477A3 (en) 1994-05-25
EP0588477B1 (en) 1997-10-15

Similar Documents

Publication Publication Date Title
NO910340L (no) Topiske preparater for behandling av menneskenegler.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
MX9708800A (es) Compuestos biciclicos aromaticos.
DE69814394D1 (de) Verwendung von levobupivacain
DE68913739T2 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
NO931413D0 (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
TR199901385T2 (xx) Piperidin t�revleri.
DE69000791T2 (de) Therapeutische mittel fuer metabolische knochenkrankheiten.
DE69330809T2 (de) Therapeutisches Agens für Neutropenie
ZA979135B (en) New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
KR930703003A (ko) 피부질환치료용 제약 조성물
RU2001123675A (ru) Средство бальзам "ГРААЛЬ" для лечения сердечно-сосудистой системы и заболеваний крови человека
ATE102478T1 (de) Kosmetische und hautbehandlungszusammensetzungen.
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari